Hanqing Dong

This inventor holds 57 USPTO granted patents and 41 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Protein Degradation. Top assignees: Arvinas Operations, Inc., Osi Pharmaceuticals, Inc., Yale University. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanqing Dong. Retrieved from https://idiyas.com/inventor/hanqing-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 57 (Patent Applications = 41)

% Patents Active = 87.7

CIPO Patents = 6 (Patent Applications = 21)

EPO Patents = 11 (Patent Applications = 48)

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 206(Granted Patents)

Forward Citations (Not Self Cited) = 132(Dec 10, 2025)

Location History:

Farmingdale, NY (US) (2008 - 2010)
Syosset, NY (US) (2010 - 2015)
Madison, CT (US) (2018 - 2024)

Company Filing History:

43 out of 67

Arvinas Operations, Inc.

patents

12 out of 118

Osi Pharmaceuticals, Inc.

5. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Alpha-Synuclein

Proteolysis

Estrogen Receptor

Cereblon

BCL6

Androgen Receptor

KRAS

Bromodomain

PROTACs

Indazole Compounds

Tetrahydronaphthalene

Fibrosarcoma

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12594264 - Modulators of alpha-synuclein proteolysis and associated methods of use (2026-04-07),

2. 12577255 - MDM2-based modulators of proteolysis and associated methods of use (2026-03-17),

3. 12569464 - Protein-protein interaction inducing technology (2026-03-10),

4. 12559506 - Indazole based compounds and associated methods of use (2026-02-24),

5. 12552783 - Modulators of proteolysis and associated methods of use (2026-02-17),

6. 12448399 - Cereblon-based KRAS degrading PROTACs and uses related thereto (2025-10-21),

7. 12441708 - Cereblon ligands and bifunctional compounds comprising the same (2025-10-14),

8. 12427144 - Compounds and methods for the targeted degradation of androgen receptor (2025-09-30),

9. 12312316 - Compounds and methods for the targeted degradation of androgen receptor (2025-05-27),

10. 12310975 - Modulators of BCL6 proteolysis and associated methods of use (2025-05-27),

11. 12286419 - Methods of manufacturing a bifunctional compound (2025-04-29),

12. 12275716 - Modulators of estrogen receptor proteolysis and associated methods of use (2025-04-14),

13. 12264157 - Compounds and methods for the enhanced degradation of targeted proteins (2025-04-01),

14. 12239711 - Cereblon ligands and bifunctional compounds comprising the same (2025-03-04),

15. 12172981 - Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders (2024-12-24),

Title: Hanqing Dong - Pioneering Inventor from Madison, CT

Introduction: Hanqing Dong is a distinguished inventor hailing from Madison, CT, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hanqing Dong holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights: Throughout his illustrious career, Hanqing Dong has consistently pushed the boundaries of innovation, with a focus on developing practical inventions that have the potential to revolutionize industries.

Collaborations: Hanqing Dong has collaborated with leading research institutions, universities, and companies to further his inventive pursuits, fostering a culture of innovation and knowledge-sharing.

Conclusion: Hanqing Dong's relentless passion for innovation and his remarkable contributions to the world of technology make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.